Evidence‐based clinical practice guidelines for liver cirrhosis 2020-Reference-Cited by-同舟云学术

Evidence‐based clinical practice guidelines for liver cirrhosis 2020

Published:2021-07 Issue:7 Volume:51 Page:725-749
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Yoshiji Hitoshi¹²,Nagoshi Sumiko¹,Akahane Takemi¹^ORCID,Asaoka Yoshinari¹,Ueno Yoshiyuki¹,Ogawa Koji¹,Kawaguchi Takumi¹,Kurosaki Masayuki¹,Sakaida Isao¹,Shimizu Masahito¹,Taniai Makiko¹,Terai Shuji¹,Nishikawa Hiroki¹,Hiasa Yoichi¹,Hidaka Hisashi¹,Miwa Hiroto¹,Chayama Kazuaki³,Enomoto Nobuyuki¹,Shimosegawa Tooru¹,Takehara Tetsuo³,Koike Kazuhiko¹

Affiliation:

1. Guidelines Committee for Creating and Evaluating the Evidence‐Based Clinical Practice Guidelines for Liver Cirrhosis The Japanese Society of Gastroenterology/the Japan Society of hepatology Tokyo Japan

2. Department of Gastroenterology Nara Medical University Nara Japan

3. The Japan Society of Hepatology Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13678

Reference215 articles.

1. Evidence-based clinical practice guidelines for liver cirrhosis 2015

2. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

3. GRADE guidelines: 2. Framing the question and deciding on important outcomes

4. GRADE guidelines 6. Rating the quality of evidence—imprecision

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study;Clinical Nutrition ESPEN;2024-10

2. Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy;Liver International;2024-09-02

3. Therapeutic effect of fecal microbiota transplantation on rats with liver cirrhosis and its influence on gut microbiota;IRAN J BASIC MED SCI;2024

4. Safety and efficacy of dapagliflozin in recurrent ascites: a pilot study;2024-08-17

5. Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis;Journal of Gastroenterology;2024-07-28